Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)
1.530
-0.010
(-0.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 23, 2025
Add to My Watchlist
Headline News about Inhibikase Therapeutics, Inc. - Common Stock
Inhibikase Posts Wider Loss in Q2
August 14, 2025
Via The Motley Fool
Dow Jumps Over 100 Points; Helen Of Troy Posts Upbeat Q2 Results
October 09, 2024
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||